Public Profile

Sandoz

Sandoz, a division of Novartis, is a global leader in the pharmaceutical industry, headquartered in Switzerland (CH). Founded in 1886, Sandoz has established itself as a pioneer in generic and biosimilar medicines, focusing on high-quality, affordable healthcare solutions. With a strong presence in Europe, North America, and emerging markets, the company is dedicated to improving patient access to essential medications. Sandoz's core offerings include a diverse range of generic pharmaceuticals, biosimilars, and over-the-counter products, distinguished by their rigorous quality standards and innovative approaches. The company has achieved significant milestones, including the launch of several groundbreaking biosimilars, solidifying its position as a trusted partner in the healthcare sector. With a commitment to sustainability and patient-centric solutions, Sandoz continues to shape the future of medicine.

DitchCarbon Score

How does Sandoz's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

66

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Sandoz's score of 66 is higher than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

99%

Let us know if this data was useful to you

Sandoz's reported carbon emissions

In 2024, Sandoz reported total carbon emissions of approximately 1,740,000,000 kg CO2e, with significant contributions from Scope 1, Scope 2, and Scope 3 emissions. Specifically, Scope 1 emissions were about 82,100,000 kg CO2e, while Scope 2 emissions totalled approximately 157,600,000 kg CO2e. The majority of emissions stemmed from Scope 3, which accounted for about 1,748,800,000 kg CO2e, highlighting the extensive impact of their supply chain and product use. Sandoz has set ambitious climate commitments, aiming to reduce Scope 1 emissions by 30% from a 2020 baseline by 2030 and to achieve near-zero Scope 1 emissions by 2025. Similarly, they plan to cut Scope 2 emissions by 30% from the same baseline by 2030 and also target near-zero Scope 2 emissions by 2025. These initiatives reflect Sandoz's commitment to addressing climate change and reducing their overall carbon footprint in the pharmaceutical sector.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
75,620
00,000,000
00,000,000
00,000,000
Scope 2
158,430
000,000
000,000,000
000,000,000
Scope 3
-
-
0,000,000,000
0,000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sandoz's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sandoz is in CH, which has a very low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sandoz is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Perrigo

IE
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Biogen

US
Research and development services (73)
Updated about 23 hours ago

Viatris

US
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Upjohn Inc.

US
Financial intermediation services, except insurance and pension funding services (65)
Updated 4 months ago
DitchCarbon Score

Haleon plc

GB
Pharmaceutical Preparation Manufacturing
Updated about 22 hours ago

Alcon

CH
Health and social work services (85)
Updated about 20 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers